Global Ablation
Devices Market, by Technology Type (Radiofrequency Ablation, Microwave
Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial
Thermal Ablation, and Others), by Application (Cancer, Ophthalmology, Urology,
Gynaecology, Cardiovascular, and
Orthopedic), by Function (Automatic and Robotic), by Procedure (Tumor Ablation,
Varicose Veins, Atrial Fibrillation, Aesthetics- Skin Rejuvenation and
Tightening, Laser and Other Energy Based Therapies), by End User (Hospitals,
Ambulatory Surgical Centers, and Specialty), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at
US$ 4,290.82 million in 2019 and is
expected to exhibit a CAGR of 10.9% over the forecast period (2019-2027).
Increasing acquisitions, mergers
and collaborations by key players is expected to drive the global ablation
devices market growth during the forecast period. For instance in 2016, Boston
Scientific Corporation, acquired Cosman Medical, Inc., a manufacturer of
radiofrequency ablation (RFA) systems. This acquisition has further expanded
Boston Scientific’s Spinal Cord Stimulator and Deep Brain Stimulation Systems
portfolio. Furthermore, in 2015, EDAP TMS announced a multinational strategic
OEM partnership with Quanta System, a leading manufacturer of medical lasers
for surgical applications. Through this partnership, Quanta manufactures
customized urological stone lasers to be sold under the EDAP brand.
Additionally, in 2013, Abbott Laboratories acquired IDEV Technologies, a
privately-owned company focused on developing next-generation medical devices
for use of ablation catheters in electrophysiology.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/464
The company also acquired two
other catheter-based medical device companies, namely Advanced Cardiac
Therapeutics, Inc. and Topera, Inc., in order to enter the electrophysiology
ablation devices market.
Browse 52 Market Data Tables and
48 Figures spread through 305 Pages and in-depth TOC on "Global Ablation
Devices Market, by Technology Type (Radiofrequency Ablation, Microwave
Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial
Thermal Ablation, and Others), by Application (Cancer, Ophthalmology, Urology,
Gynaecology, Cardiovascular, and
Orthopedic), by Function (Automatic and Robotic), by Procedure (Tumor Ablation,
Varicose Veins, Atrial Fibrillation, Aesthetics- Skin Rejuvenation and Tightening,
Laser and Other Energy Based Therapies), by End User (Hospitals, Ambulatory
Surgical Centers, and Specialty), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"
he global ablation devices market
is expected to witness significant growth over the forecast period, owing to
increasing regulatory approval for ablation Devices, For instance, in April
2019, Innoblative Designs, Inc., received U.S. Food and Drug Administration
(FDA) clearance for its SIRA RFA Electrosurgical Device, a novel radiofrequency
ablation (RFA) applicator for electrosurgery.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/ablation-devices-market-464
Key Takeaways of the Global
Ablation Devices Market:
The global ablation devices
market expected to exhibit a CAGR of 10.9% over the forecast period
(2019–2027), owing to increasing acquisition, merger and collaboration
activities by key player.
Among technology type, the
radiofrequency ablation segment is expected to account for a major revenue
share by 2027, owing to increasing launches of radiofrequency ablation systems.
For instance, in February 2019, Medtronic Plc. Launched Accurian Radiofrequency
ablation system in the U.S. for nerve tissue ablation and also received 510(k)
clearance from the US Food and Drug Administration (FDA).
Major players operating in the
global ablation devices market include Arthrex, Boston Scientific Corporation,
Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Halyard
Health, Abbott Laboratories, EDAP TMS S.A., AtriCure, Inc., and Smith &
Nephew.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/464
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment